Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SUPT4H1P2 is a pseudogene in humans named "SPT4 homolog, DSIF elongation factor subunit pseudogene 2". It does not encode a protein and has no known biological function or disease association. SUPT4H1P2 should not be considered a functional molecular target or receptor[2][4][6][9]. This gene is classified as a pseudogene, meaning it likely arose by duplication or retrotransposition from its functional parental gene (SUPT4H1), but has since lost the ability to encode a functional protein. The canonical, functional form related to SUPT4H1P2 is SUPT4H1 (SPT4 homolog, DSIF elongation factor subunit), which functions as part of the DSIF complex in transcription elongation[8]. SUPT4H1P2, however, is a non-functional copy and is not a therapeutic target[2][4][9].
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on SPT4 homolog, DSIF elongation factor subunit pseudogene 2 (SUPT4H1P2).